Skip to main content
Premium Trial:

Request an Annual Quote

If Jonathan Eisen Offers You an Award, You Probably Want to Decline

The rest of the blogosphere is teeming with excitement over the Wolbachia paper (if you missed it, check it out in our latest roundup of Science), but at the Tree of Life blog, it has led Jonathan Eisen to start the new "Adaptationomics" award for scientists who "resort to silly adaptationist arguments for observations." Just finding something unexpected doesn't mean it's adaptive, Eisen argues, as he gives out his first commendation to Jack Werren and collaborators "for their recent press release on their new study of lateral transfer in Wolbachia." (If it's any consolation, guys, Eisen does say that he really likes the study itself.)

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.